MASTROPASQUA, Mauro Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 7.288
AS - Asia 2.531
EU - Europa 2.069
SA - Sud America 808
Continente sconosciuto - Info sul continente non disponibili 454
AF - Africa 96
OC - Oceania 8
Totale 13.254
Nazione #
US - Stati Uniti d'America 7.089
SG - Singapore 1.188
IT - Italia 822
BR - Brasile 652
HK - Hong Kong 365
CN - Cina 353
SE - Svezia 264
FR - Francia 235
RU - Federazione Russa 206
DE - Germania 141
VN - Vietnam 135
GB - Regno Unito 128
IN - India 102
CA - Canada 84
BD - Bangladesh 61
AR - Argentina 50
FI - Finlandia 47
MX - Messico 43
IQ - Iraq 39
UA - Ucraina 35
TR - Turchia 33
ID - Indonesia 32
CO - Colombia 27
BE - Belgio 26
VE - Venezuela 24
AT - Austria 23
ES - Italia 23
ZA - Sudafrica 23
MY - Malesia 21
EC - Ecuador 20
PK - Pakistan 20
PL - Polonia 19
SA - Arabia Saudita 19
PH - Filippine 18
JP - Giappone 17
NL - Olanda 17
KR - Corea 16
UZ - Uzbekistan 16
CL - Cile 15
IE - Irlanda 14
NP - Nepal 14
GT - Guatemala 11
JO - Giordania 10
MA - Marocco 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
DZ - Algeria 9
EG - Egitto 9
IR - Iran 9
DO - Repubblica Dominicana 7
KE - Kenya 7
NI - Nicaragua 7
PY - Paraguay 7
RO - Romania 7
TN - Tunisia 7
AU - Australia 6
HR - Croazia 6
IL - Israele 6
KZ - Kazakistan 6
LT - Lituania 6
OM - Oman 6
RS - Serbia 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
AL - Albania 5
CI - Costa d'Avorio 5
HN - Honduras 5
PE - Perù 5
TH - Thailandia 5
AZ - Azerbaigian 4
BB - Barbados 4
BG - Bulgaria 4
BO - Bolivia 4
CW - ???statistics.table.value.countryCode.CW??? 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
EE - Estonia 4
ET - Etiopia 4
HU - Ungheria 4
JM - Giamaica 4
LB - Libano 4
PR - Porto Rico 4
SN - Senegal 4
CH - Svizzera 3
KW - Kuwait 3
LC - Santa Lucia 3
MD - Moldavia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
BN - Brunei Darussalam 2
GE - Georgia 2
KG - Kirghizistan 2
MN - Mongolia 2
MU - Mauritius 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
Totale 12.770
Città #
Ashburn 686
Chandler 579
Fairfield 573
Singapore 571
San Jose 500
Hong Kong 363
Milan 313
Houston 280
Woodbridge 278
Seattle 251
Wilmington 222
Nyköping 205
Cambridge 200
Council Bluffs 176
Ann Arbor 135
Lawrence 113
Beijing 111
Lauterbourg 111
New York 104
Los Angeles 98
Roxbury 91
Rome 88
Santa Clara 78
Dallas 73
Des Moines 71
Jacksonville 61
Columbus 60
São Paulo 54
Paris 51
The Dalles 50
Bari 47
Ho Chi Minh City 45
San Diego 44
Buffalo 35
London 34
Chicago 33
Princeton 33
Frankfurt am Main 31
Hanoi 29
Munich 29
Nanjing 28
Nuremberg 28
Brussels 26
Cressa 24
Figino 24
Pune 24
Brooklyn 23
Moscow 23
Helsinki 22
Rio de Janeiro 22
Atlanta 21
Falls Church 21
Belo Horizonte 20
Turin 20
Boardman 19
Toronto 19
Boston 18
Inglewood 18
Naples 18
Tokyo 17
Washington 16
Dearborn 15
Philadelphia 15
Baghdad 14
Brasília 14
Denver 14
Dublin 14
Las Vegas 14
Montreal 14
Phoenix 14
Warsaw 14
Amsterdam 13
Jakarta 13
San Mateo 13
Tashkent 13
Istanbul 12
San Francisco 12
Vienna 12
Chennai 11
Edinburgh 11
North Bergen 11
Curitiba 10
Guatemala City 10
Kathmandu 10
Queens 10
Recife 10
Seoul 10
Ardabil 9
Augusta 9
Bologna 9
Campinas 9
Kuala Lumpur 9
Leawood 9
Madrid 9
Manchester 9
Mexico City 9
Orem 9
Stockholm 9
Charlotte 8
Dhaka 8
Totale 7.795
Nome #
Tumore a Cellule del Sertoli a Grandi Cellule Calcificante (TCSGCC) ad evoluzione maligna. Studio di un caso 901
Analytical validation of a standardized scoring protocol for Ki67: Phase 3 of an international multicenter collaboration 240
How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss working group of breast- and gynecopathologists 228
Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation 189
A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer 188
Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma 179
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial 176
Adenomyoepithelioma 171
A new technique for foetal brain fixation and extraction 147
Tumore a Cellule del Sertoli a Grandi Cellule Calcificante (TCSGCC) ad evoluzione maligna. Studio di un caso. 146
Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression 137
Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial 135
An international study to increase concordance in Ki67 scoring 132
Testicular Modification Induced by Low Alcohol Intake in Rat. Morphometric Investigations and bcl-2 Oncogene Expression 130
A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer 128
MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome 128
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration 127
Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study 127
Microscopic esophagitis and Barrett in endoscopy-negative gastroesophageal reflux disease (GERD) 126
Abstract S4-6: An international Ki67 reproducibility study 124
BETA-GALACTOSYLCERAMIDASE PROMOTES MELANOMA GROWTH VIA MODULATION OF CERAMIDE METABOLISM 123
Angiomixoma aggressivo dello scroto. Studio di un caso 121
Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration 120
Abstract P5-07-02: Systematic analysis and modulation of Ki67 interobserver variance in 9069 patients from three clinical trials – How much pathologist concordance is needed for meaningful biomarker results? 120
Pathological complete response after preoperative systemic therapy and outcome: Relevance of clinical and biologic baseline features 117
Accelerated partial breast irradiation with intraoperative electrons: Using GEC-ESTRO recommendations as guidance for patient selection 117
Analytical validation of a standardized scoring protocol for Ki67: Phase-3 of an international multicenter collaboration 113
Correlation of size and focality with prognosis in small breast carcinoma: a single institution case series 113
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer 110
Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgery 109
Progesterone receptor loss identifies luminal B breast cancer subgroups at higher risk of relapse 109
Paget's disease as a local recurrence after nipple-sparing mastectomy: Clinical presentation, treatment, outcome, and risk factor analysis 109
Regulation of mRNA and protein levels of beta 1 integrin variants in human prostate carcinoma 108
Peri-Prostatic Epidermal Inclusion Cyst: A Case Report 108
An international ki67 reproducibility study 108
Mechanical characterization of human urethra 107
Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression 106
Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer 106
Heterogeneity of triple-negative breast cancer: Histologic subtyping to inform the outcome 104
Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer 104
Microbiopsia mammaria stereotassica. 102
Malignant Large Cell Calcifying Sertoli Cell Tumor of the Testis (LCCSCTT). Report of a case in an elderly man and review of the literature 102
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes 102
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer. Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy 101
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer 101
Abstract P1-15-06: Lobular histology and partial breast irradiation: To what extent is it a cautionary parameter? 100
Primary and secondary angiosarcomas of the breast: A single institution experience 100
Intra-Cystic (In Situ) Mucoepidermoid Carcinoma: A Clinico-Pathological Study of 14 Cases 100
Sensitivity and Detection Rate of a 12-Core Trans-Perineal Prostate Biopsy: Preliminary Report 99
Atypical Ductal Hyperplasia after Vacuum-Assisted Breast Biopsy: Can We Reduce the Upgrade to Breast Cancer to an Acceptable Rate? 99
A New Possible Cut-Off of Cytokeratin 19 mRNA Copy Number by OSNA in the Sentinel Node of Breast Cancer Patients to Avoid Unnecessary Axillary Dissection: A 10-Year Experience in a Tertiary Breast Unit 98
Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies 98
Mammary stereotaxic core-biopsy by Mammotome: an alternative to frozen section examination 97
How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology 97
High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy 96
Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast 96
Osteoclast-like stromal giant cells in invasive ductal breast cancer: A case series 96
Traditional molecular markers and response to adjuvant endocrine or trastuzumab-based therapies 95
Breast cancer subtypes and outcome after local and regional relapse 95
Basaloid cell carcinoma of the prostate. Case report and review of the literature 95
Metastatic tumors of the oro-facial tissues: Clear cell renal cell carcinoma. A clinico-pathological study of seven cases 95
Advances and controversies in management of breast ductal carcinoma in situ (DCIS) 95
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial 94
Risk of locoregional recurrence in patients with false-negative frozen section or close margins of retroareolar specimen in nipple-sparing mastectomy 94
Positive axillary sentinel lymph node: Is axillary dissection always necessary? 93
Outcome of special types of luminal breast cancer 93
Complete removal of the lesion as a guidance in the management of patients with breast ductal carcinoma in Situ 93
Mesotelioma multicistico benigno del pericardio. Descrizione di un caso 92
Benign multicystic mesothelioma of the pericardium (BMMP). A case report 92
The prognostic role of high Ki-67 in early breast cancer patients who do not receive axillary dissection or axillary radiotherapy 92
Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast 92
Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy 92
Clinical and pathological assessment of high-risk ductal and lobular breast lesions: What surgeons must know 91
What can the pathologist offer for optimal treatment choice? 91
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): A phase 3 randomised controlled trial 91
COVID-19 And Breast Fine Needle Aspiration Cytology Method: What Should We Change? 90
Wireless ultrasound-guided vacuum-assisted breast biopsy: Experience in clinical practice at European Institute of Oncology 90
Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation 89
β3 adrenergic receptor as potential therapeutic target in ADPKD 89
null 88
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes 87
Prognostic significance of Ki-67 in node-negative (pN0), triple-negative (TN) breast cancer (BC) 86
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer 85
Primary Breast Extranodal Marginal Zone Lymphoma in Primary Sjögren Syndrome: Case Presentation and Relevant Literature 85
Atypical vascular lesions after radiation therapy for breast cancer: A clinicopathologic study and outcomes of 24 cases 84
Metastatic Lung Cancer to the Head and Neck: A Clinico-Pathological Study on 21 Cases with Narrative Review of the Literature 83
HER2-negative (1+) breast cancer with unfavorable prognostic features: To FISH or not to FISH? 83
TEN-YEAR SAFETY AND EFFICACY ANALYSES OF THE BIG 02-98 PHASE III TRIAL WITH AN EXPLORATORY ANALYSIS ON THE ROLE OF KI67 IN PREDICTING BENEFIT OF ADJUVANT DOCETAXEL IN ER POSITIVE PATIENTS 82
Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: Current and resolving controversies on the basis of the European Institute of Oncology experience 82
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy 82
Outcome and medial presentation of breast cancer: European Institute of Oncology experience 81
Breast cancer subtypes and outcome after local and regional relapse 81
Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons 81
Evaluation of computer-aided diagnosis in breast ultrasonography: Improvement in diagnostic performance of inexperienced radiologists 80
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes 79
Male breast cancer 79
Robotic vs open prostatectomy in a laparoscopically naive centre: A matched-pair analysis 78
LOCOREGIONAL RECURRENCE AFTER CONSERVATIVE SURGERY FOR DUCTAL BREAST CANCER: ROLE OF SURGICAL MARGIN 78
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy 77
Studio delle regioni organizzatrici argirofile del nucleolo (AgNORs) nelle neoformazioni colo-rettali quale indice di malignità biologica. [Argyrophilic nucleolar organizer regions (AgNORs) as malignancy biomarkers in colorectal neoplasms]. 76
Totale 11.525
Categoria #
all - tutte 62.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.086


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022630 0 0 0 19 55 110 13 36 40 95 52 210
2022/20231.466 154 149 91 147 105 190 50 234 207 20 95 24
2023/2024525 41 84 34 24 51 121 21 42 3 14 35 55
2024/20251.998 17 34 159 90 106 214 172 139 136 139 285 507
2025/20264.898 585 207 172 292 493 241 497 123 411 395 938 544
2026/20271.132 121 221 300 490 0 0 0 0 0 0 0 0
Totale 13.254